{"task_id": "bfff26eaa7b78c47", "source": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf (Part 453/464)", "text": "nthoma............................... 61\nIndex\n447\n\n--- Page 469 ---\nErysipelas.....................................247, 253\nErythema migrans .......................234\u2013235\nErythema multiforme .........................172,\n267, 276\u2013277, 282, 365\u2013366, 372\nErythema nodosum ............ 122, 121, 172,\n234, 250, 266\u2013267, 276\u2013277, 279,\n282\u2013283, 291, 373\u2013374, 420\nErythrocyte sedimentation rate\n(ESR) ........................... 13, 15, 51, 53,\n121, 127, 149\u2013150, 163, 172\u2013173, 233,\n235, 248\u2013249, 274, 276, 278, 280, 282,\n284, 286\u2013287, 289\u2013292, 302, 314, 322,\n327, 344, 367\u2013368, 383, 398, 421\nEsophageal cancer..........25\u201326, 195\u2013196,\n374, 406\nEsophageal dysphagia.........................112\nEsophagitis ..... 25\u201326, 112\u2013114, 118\u2013119,\n148, 260, 265\nEssential thrombocytosis (ET)..............43,\n164\u2013167\nEssential tremor.................................... 59\nEthics ...................................395, 427\u2013428\nEthnic neutropenia..............................148\nEthylene glycol overdose ....................107\nEtoposide.... 167\u2013168, 173, 175\u2013176, 182,\n187, 189, 202, 214, 216, 226, 230, 298\nEuthanasia ...................................395, 428\nEvan\u2019s syndrome..........................151, 153\nExanthematous lesions................364\u2013365\nExanthems...................233\u2013234, 364\u2013365\ndrug-related ....................... 372\u2013373\nExemestane .................................192, 227\nExercise induced asthma.................... 2\u20133\nExtended spectrum b-lactamase\n(ESBL)............................................253\nExtraocular eye movements........306, 318\nEye lymphoma.....................................176\nF\nFacial droop.................................305, 307\nstroke/TIA, 305, 307\nFacial nerve lesions..............................307\nFacial nerve palsy ................................235\nFacial telangiectasia.............118, 364, 371\nFactor V Leiden............8\u20139, 156, 158\u2013159\nFalls.............................. 83, 301, 313, 315,\n320, 338, 377, 382\u2013383, 385, 390, 405\nFamciclovir ..................................265, 366\nFamilial adenomatous polyposis\n(FAP).................... 197\u2013199, 204, 223,\n225\u2013226, 297\nFamilial benign hypocalciuric\nhypercalcemia ......................353\u2013354\nFamilial combined hyperlipidemia....... 62\nFamilial dyslipidemia............................ 62\nFanconi\u2019s anemia.................................153\nFanconi\u2019s syndrome.............................. 78\nFat embolism..................... 10, 20, 93, 147\nFatigue................................. 5, 27, 35, 51,\n55, 73, 138, 144\u2013146, 167, 169\u2013172,\n174, 178, 180, 185, 188\u2013190, 193, 195,\n197, 199, 202\u2013204, 207, 209\u2013210,\n212\u2013213, 215, 217\u2013218, 226\u2013227,\n235, 250, 263, 278, 280, 287\u2013288, 290,\n308\u2013309, 313, 322, 338, 343\u2013344, 349,\n357, 389\u2013390, 394, 397, 405, 420\u2013421\nFebrile neutropenia............ 148, 181, 193,\n230, 236\u2013238, 268\u2013269\nFecal osmotic gap................................124\nFelty syndrome....................................278\nFemoral nerve .............................326, 331\nFerritin.................121, 125, 128, 134, 138,\n144\u2013145, 147, 150, 277, 420\nFever\nendocarditis..............3, 8, 47, 50\u201353,\n233\u2013235, 241\u2013242, 253, 258,\n276\u2013277, 282, 288, 374, 420, 422\nneurological symptoms...... 241\u2013242\nneutropenic.........148, 233, 237\u2013238\nNYD ............................................ 233\npolyarthritis ..........51, 122, 277, 283,\n365, 422\npost-operative .....247, 302, 422, 425\nrash..................................... 149, 235\nsepsis.......... 3, 6, 8, 19, 33, 137, 148,\n162, 178, 238, 244, 258, 275, 277,\n286, 344\nskin infections..................... 147, 274\nof unknown origin (FUO).... 233\u2013234\nurinary symptoms..........68, 127, 212\nwith travel .......................... 238\u2013241\nFibrates................ 61\u201362, 79, 332, 339, 425\nFibromyalgia.......... 18, 127, 287\u2013288, 332\nFixed drug eruption ....................372\u2013373\nFlaccidity..............................................303\nFlash pulmonary edema..................38, 60\nFluconazole......... 181, 231, 237\u2013238, 245,\n260, 265\u2013269, 386\n5-flucytosine........................................268\nFludarabine..........138, 146, 171, 175, 178,\n181, 226, 230\nFluoroquinolones................ 7, 63, 97, 100,\n123, 128, 241, 245, 255, 257, 413\n5-fluorouracil ...... 193, 196, 198\u2013200, 202,\n204\u2013205, 226, 230\u2013231, 370\u2013372\nFlushing......59, 61, 80, 201\u2013202, 364, 371\nFocal liver lesion..................................205\nFocal Neurological Deficits ...........25, 152,\n176, 291, 297, 301, 378\u2013379\nstroke.......................................... 301\nFocal nodular hyperplasia\n(FNH) ....................................205\u2013206\nFocal segmental glomerulosclerosis\n(FSGS) .........................68, 70\u201372, 172\nFollicular lymphoma............170, 173\u2013175\nFollicular lymphoma international\nprognostic index (FLIPI)................175\nFondaparinux....... 9, 29, 89, 100, 157, 161\nFoot examination ................................338\nFoscarnet .............................................265\nFracture index for postmenopausal\nwomen .........................................355\nFragmented cells.................................163\nFrailty...........................................377, 381\nFrontotemporal dementia ...........378\u2013379\nFunctional dyspepsia...........113\u2013114, 127\nFungal infections........ 228, 234, 236, 238,\n243, 265\u2013267, 367\nFutility..................................................428\nG\nGail model ...........................................190\nGait assessment...........................322, 377\nGallavardin phenomenon............... 46\u201347\nGallstone pancreatitis..................117, 139\nGallstones ..............................61, 138, 202\nGanciclovir...........................................265\nGastric cancer .....114\u2013115, 190, 196\u2013198,\n220\u2013221, 225\nGastroesophageal reflux disease\n(GERD) ........... 1, 12, 25\u201326, 112\u2013113,\n260, 281, 398, 412\nGastroparesis ............. 111, 113, 115, 337,\n340, 397\nGemcitabine ....................... 175, 187\u2013188,\n192, 194, 205, 209, 216, 220, 226, 230\nGeriatrics......................................377\u2013386\nGerm cell tumor ...................20, 212\u2013213,\n215\u2013216, 219\u2013221, 228\nGestational diabetes..................337\u2013338,\n413\u2013414\nGestational hypertension.....................409\nGestational thrombocytopenia............415\nGet up and go test ......................377, 383\nGiant cell arteritis (GCA) ....... 25, 233, 276,\n289\u2013290\nGI Bleed ............ 12, 94, 97, 118\u2013120, 129,\n134\u2013135, 144\u2013145, 195, 197, 203, 238,\n350, 380, 406\u2013407, 421\nlower........................................... 120\nupper..... 12, 118\u2013120, 134, 195, 197\nGitelman\u2019s syndrome............................ 79\nGlabellar tap reflex ..............................304\nGlanzmann\u2019s thrombasthenia......154\u2013155\nGlasglow coma scale (GCS).......90\u201391, 94,\n102, 104, 108\u2013109\nGleason score ..............................210\u2013212\nGlioblastoma Multiforme.............297\u2013298\nGlobal aphasia.....................................301\nGlomerulopathies......................70\u201373, 75\nGlucocorticoids......3, 5, 61, 115, 121, 273,\n283, 286, 348\u2013352, 355, 358, 363, 368,\n371, 373\u2013374, 410\ncomplications ..................... 273, 352\nGluten..................................124, 361, 406\nGlycemic control................ 100, 340, 404,\n407, 414\nGoiter................... 1, 17, 21, 57, 104, 146,\n343\u2013345, 414\nGOLD classification................................. 4\nGonadal failure....................................420\nchemotherapy-induced .............. 216\nGoodpasture disease ...................... 12\u201313\nGottron\u2019s papules ................................281\nGout............59, 69, 84, 273, 275\u2013278, 282\nGraft versus host disease.............181\u2013182\nGraft versus leukemia effect................180\nGraham Steell murmur..............15, 46, 49\n448\nIndex", "text_length": 7740, "metadata": {"source": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf (Part 453/464)", "type": "chunk", "chunk_index": 452, "total_chunks": 464, "uploaded_by": "admin@admin.com", "upload_date": "2025-12-11T18:40:09.872080", "document_uuid": "fda2cab4-cdd9-4015-af24-46fd62c86d94", "filename": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf", "category": "medical_pdf", "section": "body", "year": null, "outdated": false, "document_id": "fda2cab4-cdd9-4015-af24-46fd62c86d94"}, "created_at": "2025-12-11T18:40:09.872903", "status": "pending"}